MissionIR Articles

POZEN is a progressive pharmaceutical company focused on transforming the way unmet medical needs are addressed by the healthcare industry. POZEN has successfully developed two self-invented products in two years, receiving FDA approval for both.…

OXiGENE is a clinical-stage biopharmaceutical company engaged in the development of novel therapeutics for treating cancer, with its primary focus on developing vascular disrupting agents that selectively disrupt abnormal blood vessels that are associated with…

Idenix Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of drugs for the treatment of human viral diseases. The company’s focus is currently on treating patients with hepatitis C infection. Building on…

OncoSec Medical is a biopharmaceutical company focused on developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy for treating solid tumor cancers. The company has based its core technology on its proprietary use of an…

Soligenix is a development-stage biopharmaceutical company engaged in developing products for the treatment of serious inflammatory diseases with unmet medical need. The company is developing several biodefense vaccines and therapeutics as well as proprietary formulations…

Newron Pharmaceuticals is a biopharmaceutical company with its focus on novel therapies for central nervous system diseases and pain. Currently, Phase III trials of safinamide are ongoing for the treatment of Parkinson’s disease, which Merck…

GeoVax Labs is a biotechnology company focused on the development of vaccines for diseases caused by HIV. The company’s vaccines are unique in expressing virus-like particles displaying the trimeric membrane-bound form of the HIV-1 envelope…

EpiCept is a specialty pharmaceutical company focused on developing and commercializing pharmaceutical products to treat pain and cancer. The company’s cancer product, Ceplene, has been approved in the European Union, and its balanced pipeline of…

Alnylam Pharmaceuticals is a biopharmaceutical company engaged in developing novel therapeutics based on RNA interference (RNAi). The company is at the helm of translating RNAi into a new class of innovative medicines, with a core…

Transcept Pharmaceuticals is a specialty pharmaceutical company engaged in developing and commercializing proprietary products that address important therapeutic needs in the field of neuroscience. Intermezzo (zolpidem tartrate) sublingual tablet C-IV is the company’s first FDA-approved…

Aradigm is an emerging specialty pharmaceutical company engaged in developing and commercializing a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases. The company’s product candidates address the treatment of bronchiectasis,…

Aastrom Biosciences is the leading developer of patient-specific, expanded multicellular therapies for treating severe, chronic cardiovascular diseases. The company’s proprietary cell-processing technology enables the manufacturing of ixmyelocel-T, which is a patent-specific multicellular therapy expanded from…

DARA BioSciences is a specialty pharmaceutical company engaged in developing and commercializing oncology treatment and supportive care products. Through agreements with various entities, the company has comprehensive commercial coverage across the national oncology market. DARA…

BioLineRx is a biopharmaceutical development company focused on building a portfolio of products to address unmet medical needs or offer advantages over currently available therapies. The company’s portfolio presently consists of six clinical stage candidates,…

SciClone Pharmaceuticals is a specialty pharmaceutical company with its primary focus in China. The company’s product portfolio includes therapies for oncology, infectious diseases and disorders of the cardiovascular, urological, respiratory and central nervous systems. Headquartered…

Orexigen Therapeutics, a biopharmaceutical company, is focused on treating obesity. Contrave, Orexigen’s lead product candidate, has completed Phase III clinical trials, and a New Drug Application has been submitted and reviewed by the U.S. Food…

Immunovaccine is a clinical-stage vaccine development company focused on the advancement of its patented DepoVax vaccine adjuvanting platform and product candidates for cancer therapy, infectious disease and animal health. Demonstrating safety and immunogenicity potential, Immunovaccine…

iCo Therapeutics is a re-profiling company engaged in re-dosing or reformulating drugs with clinical history for new or expanded indications. The company owns the global rights to three products: iCo-007, currently in a Phase I…

BioDelivery Sciences International is a specialty pharmaceutical company leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize new applications of proven therapeutics – either independently or in partnerships with third parties.…

Oragenics is dedicated to becoming a global leader in probiotics for oral health in humans and pets and in novel antibiotics against infectious disease. The company is engaged in developing, marketing and selling proprietary probiotics…